Breast CANcer Risk Assessment in Younger Women: BCAN-RAY (BCAN-RAY)
A Case Control Study of Women Aged 30-39 to Augment Breast Cancer Risk Prediction and Assess Acceptability and Preference of a Systematic Risk Prediction Approach Through Primary Care
Sponsor: Manchester University NHS Foundation Trust
A observational or N/A phase clinical study on Breast Cancer Female, this trial is ongoing. The trial is conducted by Manchester University NHS Foundation Trust and has accumulated 9 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Aug 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2023 — Aug 2023 [monthly]
Not Yet Recruiting
▶ Show 4 earlier versions
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Not Yet Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Not Yet Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Manchester University NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .